Concentrations in plasma and selected tissues of marbofloxacin after oral and intravenous administration in Bilgorajska geese (Anser anser domesticus)

References

• Andraud M, Chauvin C, Sanders P, Laurentie M. Pharmacodynamic modeling of in vitro activity of marbofloxacin against Escherichia coli strains. Antimicrobial Agents and Chemotherapy 55, 756–61, 2011 doi: 10.1128/AAC.00865-10
   PubMed Web of Science ®Google Scholar
• *Anonymous. Marbofloxacin: Summary Report (2). https://www.ema.europa.eu/documents/mrl-report/marbofloxacin-summary-report-2-committee-veterinary-medicinal-products_en.pdf (accessed 1 August 2019). European Medicines Agency, London, UK, 1999
   Google Scholar
• *Anonymous. Guideline on Determination of Withdrawal Periods for Edible Tissues. https://www.ema.europa.eu/en/documents/scientific-guideline/guideline-determinationwithdrawal-periods-edible-tissues-revision-1_en.pdf (accessed 1 August 2019). European Medicines Agency, London, UK, 2018
   Google Scholar
• Carpenter JW, Hunter RP, Olsen JH, Henry H, Isaza R, Koch DE. Pharmacokinetics of marbofloxacin in blue and gold macaws (Ara ararauna). American Journal of Veterinary Research 67, 947–55, 2006 doi: 10.2460/ajvr.67.6.947
   PubMed Web of Science ®Google Scholar
• Craig AW. Pharmacokinetic/pharmacodynamic parameters: rationale for antibacterial dosing of mice and men. Clinical Infectious Diseases 26, 1–10, 1998 doi: 10.1086/516284
   PubMed Web of Science ®Google Scholar
• de Lucas JJ, Rodríguez C, Waxman S, González F, Uriarte I, San Andrés MI. Pharmacokinetics of marbofloxacin after intravenous and intramuscular administration to ostriches. The Veterinary Journal 170, 364–68, 2005 doi: 10.1016/j.tvjl.2004.06.012
   PubMed Web of Science ®Google Scholar
• Forrest A, Ballow CH, Nix DE, Birmingham MC, Schentag JJ. Development of a population pharmacokinetic model and optimal sampling strategies for intravenous ciprofloxacin. Antimicrobial Agents and Chemotherapy 37, 1065–72, 1993
   Google Scholar
• Garcia-Montijano M, Waxman S, Sánchez C, Quetglas J, San Andrés MI, González F, Rodríguez C. The disposition of marbofloxacin in Eurasian buzzards (Buteo buteo) after intravenous administration. Journal of Veterinary Pharmacology and Therapeutics 24, 155–57, 2001 doi: 10.1046/j.1365-2885.2001.00327.x
   PubMed Web of Science ®Google Scholar
• Garcia-Montijano M, Waxman S, de Lucas JJ, Luaces I, de San Andrés MD, Rodríguez C. Disposition of marbofloxacin in vulture (Gyps fulvus) after intravenous administration of a single dose. Research in Veterinary Science 90, 288–90, 2011 doi: 10.1016/j.rvsc.2010.06.013
   PubMed Web of Science ®Google Scholar
• Grandemange E, Fournel S, Gibon H, Woehrle F. Efficacy of a single injection of marbofloxacin in the treatment of bovine respiratory disease. Revue De Medecine Veterinarie 163, 287–94, 2012
   Web of Science ®Google Scholar
• Grubb BR. Allometric relations of cardiovascular function in birds. American Journal of Physiology 245, 567–72, 1983
   PubMed Web of Science ®Google Scholar
• Haritova A, Velizarova Rusenova N, Parvanov PR, Lashev LD, Fink-Gremmels J. Integration of pharmacokinetic and pharmacodynamic indices of marbofloxacin in Turkeys. Antimicrobial Agents and Chemotherapy 50, 3779–85, 2006 doi: 10.1128/AAC.00711-05
   PubMed Web of Science ®Google Scholar
• Haritova A, Dimitrova D, Dinev T, Moutafchieva R, Lashev L. Comparative pharmacokinetics of enrofloxacin, danofloxacin, and marbofloxacin after intravenous and oral administration in Japanese quail (Coturnix coturnix japonica). Journal of Avian Medicine and Surgery 27, 23–31, 2013 doi: 10.1647/2011-032
   PubMed Web of Science ®Google Scholar
• Lashev LD, Haritova AM. Allometric analysis of antibacterial drugs in avian species. Bulgarian Journal of Veterinary Medicine 15, 93–109, 2012
   Google Scholar
• Lashev LD, Dimitrova DJ, Milanova A, Moutafchieva RG. Pharmacokinetics of enrofloxacin and marbofloxacin in Japanese quails and common pheasants. British Poultry Science 56, 255–61, 2015 doi: 10.1080/00071668.2014.998989
   PubMed Web of Science ®Google Scholar
• Levison ME, Levison JH. Pharmacokinetics and pharmacodynamics of antibacterial agents. Infectious Disease Clinics of North America 23, 791–815, 2009. doi: 10.1016/j.idc.2009.06.008
   PubMed Web of Science ®Google Scholar
• Liu X, Wang Y. Current situation, problems and proposals for waterfowl industrial development in China. Research of Agricultural Modernization 33, 140–44, 2012.
   Google Scholar
• Plumb DC. Plumb’s Veterinary Handbook, 7th ed. Wiley-Blackwell Publishing, Ames, IA, USA, 2011
   Google Scholar
• Pouplin T, Bang ND, Toi PV, Phuong PN, Dung NH, Duong TN, Caws M, Thwaites GE, Tarning J, Day JN. Naïve-pooled pharmacokinetic analysis of pyrazinamide, isoniazid and rifampicin in plasma and cerebrospinal fluid of Vietnamese children with tuberculous meningitis. BMC Infectious Diseases 16, 144, 2016 doi: 10.1186/s12879-016-1470-x
   PubMed Web of Science ®Google Scholar
• Pudyszak K. Gęś biłgorajska – wczoraj i dziś. Hodowca Drobiu 1, 30–3, 2006
   Google Scholar
• Shi F, Tang H, Xie W, Anees A, Yang Z, Zhang X. Pharmacokinetic study of enrofloxacin in Tianfu geese. The Journal of Animal & Plant Sciences 24, 113–9, 2014
   Web of Science ®Google Scholar
• Thomas E, Caldow GL, Borell D, Davot JL. A field comparison of the efficacy and tolerance of marbofoxacin in the treatment of bovine respiratory disease. Journal of Veterinary Pharmacology and Therapeutics 24, 353–8, 2001 doi: 10.1046/j.1365-2885.2001.00333.x
   PubMed Web of Science ®Google Scholar
• Toutain PL. Antibiotic treatment of animals – a different approach to rational dosing. The Veterinary Journal 165, 98–100, 2003 doi: 10.1016/S1090-0233(02)00271-X
   PubMed Web of Science ®Google Scholar
• Toutain PL, Bousquet-Melou A. Plasma clearance. Journal of Veterinary Pharmacology and Therapeutics 27, 415–25, 2004 doi: 10.1111/j.1365-2885.2004.00605.x
   PubMed Web of Science ®Google Scholar
• Toutain PL, del Castillo JR, Bousquet-Mélou A. The pharmacokinetic-pharmacodynamic approach to a rational dosage regimen for antibiotics. Research in Veterinary Science 73, 105–14, 2002 doi: 10.1016/S0034-5288(02)00039-5
   PubMed Web of Science ®Google Scholar
• *Toutain PL, Ferran A, Bousquet-Melou A. Species differences in pharmacokinetics and pharmacodynamics. In: Cunningham F, Elliott J, Lees P (eds). Comparative and Veterinary Pharmacology. 1st ed., Pp 19–48. Springer-Verlag, Berlin, Germany, 2010
   Google Scholar
• Turnidge J. Pharmacokinetics and pharmacodynamics of fluoroquinolones. Drugs 58, 29–36, 1999 doi: 10.2165/00003495-199958002-00006
   PubMed Web of Science ®Google Scholar
• Urzúa N, Errecalde C, Prieto G, Lüders C, Picco E, Paula Tonini M. Plasma pharmacokinetics and muscle disposition of marbofloxacin in chickens. Iranian Journal of Veterinary Medicine 10, 1–6, 2016
   Google Scholar
• Vercelli C, De Vito V, Salvadori M, Barbero R, Re G, Gennero MS, Giorgi M. Blood concentration of marbofloxacin and its in vivo effect in yellow-bellied slider turtles (Trachemys scripta scripta), after a single intracoelomic injection at three dose rates. Journal of Exotic Pet Medicine 25, 295–304, 2016 doi: 10.1053/j.jepm.2016.06.011
   Web of Science ®Google Scholar
• Yang F, Yang YR, Wang L, Huang XH, Qiao G, Zeng ZL. Estimating marbofloxacin withdrawal time in broiler chickens using a population physiologically based pharmacokinetics model. Journal of Veterinary Pharmacology and Therapeutics 37, 579–88, 2014 doi: 10.1111/jvp.12137.
   PubMed Web of Science ®Google Scholar
• Yuan LG, Wang R, Sun LH, Zhu LX, Luo XY, Sun J, Fang BH, Liu YH. Pharmacokinetics of marbofloxacin in Muscovy ducks (Cairina moschata). Journal of Veterinary Pharmacology and Therapeutics 34, 82–5, 2011 doi: 10.1111/j.1365-2885.2010.01207.x
   PubMed Web of Science ®Google Scholar
• *Non-peer-reviewed
   Google Scholar